CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
- Resource Type
- Article
- Source
- Cell Death & Disease; May2023, Vol. 14 Issue 5, p1-15, 15p
- Subject
- Language
- ISSN
- 20414889